Alyeska Investment Group
KYTH

Alyeska Investment Group’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Alyeska Investment Group’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-28,342
Closed -$928K – 587
2014
Q3 		$928K Buy
+28,342
New +$998K 0.02% 332
2014
Q1 		– Sell
-53,092
Closed -$1.98M – 454
2013
Q4 		$1.98M Buy
+53,092
New +$2.2M 0.08% 230

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Alyeska Investment Group's KYTH Position: Q4 2014 in Review

Alyeska Investment Group sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2014, closing a stake of 28,342 shares — an estimated $928K sold.

Alyeska Investment Group first reported a position in KYTH in Q4 2013 and held it in 2 quarters. The position peaked at $1.98M in Q4 2013. 106 funds tracked by Wall St. Rank hold KYTH as of Q4 2014.

  • Alyeska Investment Group reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2014 after selling out during the quarter.
  • Alyeska Investment Group sold 28,342 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2014, an estimated $928K.
  • Alyeska Investment Group first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 2 quarters.
  • Alyeska Investment Group's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.98M in Q4 2013.
  • 106 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2014.

Based on Alyeska Investment Group's 13F filing for Q4 2014, filed 17 Feb 2015.